BridgeBio Pharma (BBIO) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.69% |
| Dec 31, 2025 | -7.94% |
| Sep 30, 2025 | -8.72% |
| Jun 30, 2025 | -8.52% |
| Mar 31, 2025 | -12.39% |
| Dec 31, 2024 | -19.58% |
| Sep 30, 2024 | -12.68% |
| Jun 30, 2024 | -4.29% |
| Mar 31, 2024 | 22.76% |
| Dec 31, 2023 | -12.37% |
| Sep 30, 2023 | 11.47% |
| Jun 30, 2023 | -11.25% |
| Mar 31, 2023 | 2.41% |
| Dec 31, 2022 | -10.23% |
| Sep 30, 2022 | -11.29% |
| Jun 30, 2022 | 2.64% |
| Mar 31, 2022 | -20.07% |
| Dec 31, 2021 | -17.35% |
| Sep 30, 2021 | -61.50% |
| Jun 30, 2021 | -17.50% |
| Mar 31, 2021 | -466.44% |
| Dec 31, 2020 | -50.76% |
| Sep 30, 2020 | -33.72% |
| Jun 30, 2020 | -27.48% |
| Mar 31, 2020 | -5.22% |
| Dec 31, 2019 | -9.19% |
| Sep 30, 2019 | 146.88% |
| Jun 30, 2019 | -31.93% |
| Mar 31, 2019 | -17.70% |
| Dec 31, 2018 | 127.42% |
| Sep 30, 2018 | -18.84% |